Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is N/A as of 2026-10-06T18:39:01.356Z.
Calculation as of: 2026-10-06T18:39:01.356Z.
Quote observation: 2026-10-06T18:34:15.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
N/A
Market Cap
$229.78M
EV/Assets Ratio
0.44x
TTM Avg
0.64x
3Y Avg
0.96x
5Y Avg
1.09x
Market Cap
$234.66M
EV/Assets Ratio
1.52x
TTM Avg
1.39x
3Y Avg
1.06x
5Y Avg
0.91x
Market Cap
$234.54M
EV/Assets Ratio
0.67x
TTM Avg
0.98x
3Y Avg
1.52x
5Y Avg
2.08x
Market Cap
$236.00M
EV/Assets Ratio
1.90x
TTM Avg
1.10x
3Y Avg
1.04x
5Y Avg
1.55x
Market Cap
$236.58M
EV/Assets Ratio
1.63x
TTM Avg
1.00x
3Y Avg
2.24x
5Y Avg
2.24x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vogenx Inc. (VOGX) | $230.00M | N/A | N/A | N/A | N/A |
| MacroGenics, Inc. (MGNX)vs › | $229.78M | 0.44x | 0.64x | 0.96x | 1.09x |
| Biodesix, Inc. (BDSX)vs › | $229.14M | 2.84x | 2.04x | 1.85x | 1.57x |
| BioAge Labs Inc. (BIOA)vs › | $229.12M | 0.40x | 1.20x | 1.18x | 1.18x |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $234.66M | 1.52x | 1.39x | 1.06x | 0.91x |
| SIGA Technologies, Inc. (SIGA)vs › | $234.54M | 0.67x | 0.98x | 1.52x | 2.08x |
| InflaRx N.V. (IFRX)vs › | $232.72M | 0.35x | 1.18x | 0.83x | 0.85x |
| Utah Medical Products, Inc. (UTMD)vs › | $236.00M | 1.90x | 1.10x | 1.04x | 1.55x |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $236.58M | 1.63x | 1.00x | 2.24x | 2.24x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $237.30M | 0.39x | 0.72x | 1.42x | 1.05x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
